Built for growth, valuation, and exit outcomes
We work with founders, executive teams, and private equity operators who already have strong businesses. And they need those businesses to be understood, trusted, and valued by buyers.
Legacy DNA is a growth partner for mid-market healthtech and pharmacy companies operating under real enterprise value pressure.
Book a Strategic Fit Call →
Every business has a commercial DNA. Most companies never fully unlock the value within it.
Legacy DNA refers to the underlying commercial structure that explains why a business works and whether that value can travel beyond the founder, the current team, or a single growth phase.
Our work lives at the intersection of growth, credibility, and transferability. We focus on what buyers care about, how value is created, and whether it will hold up under scrutiny.
Founded by Dr. Roxie Mooney →
OUR MISSION
To help mid-market healthcare leaders build commercial systems that translate growth into enterprise value that lasts — beyond a single growth phase, a single leader, or a single transaction.
OUR VISION
A healthcare ecosystem where companies capable of improving lives reach the scale and valuation they deserve — because they were built, positioned, and valued to endure.
What Legacy DNA does
Legacy DNA builds the commercial system that closes the gap between what your business is producing and what it's actually worth. The Enterprise Value Creation System™ is the framework we use — a six-stage model that maps where alignment is breaking and what to fix, in the order that creates the most leverage.
This is not strategy consulting or agency work. We operate inside the business to build the system. The work is senior-led by Dr. Roxie Mooney and designed to hold up in board presentations, investor conversations, and diligence rooms.
A Strategic Fit Call is 30 minutes. We'll identify where growth may be breaking and whether the Enterprise Value Creation System™ is the right fit for where your company is right now.
Book Strategic Fit Call →
16+ years. Four successful exits.
One repeatable approach.
$750M → $2B
BioPlus scaled to two acquisitions
$50M → $500M
Mid-market healthtech trajectories guided
100+
Healthcare/healthtech product launches supported
"Roxie didn't just observe from the edges. She helped us translate complexity into clarity and made sure the decisions we were making supported not just the next quarter, but what the company would be worth when it was time to hand it to someone else."
— Mark Montgomery, Former CEO, BioPlus Specialty Pharmacy
Senior-led. Not delegated.
Legacy DNA is a small, senior-led firm. We work with a limited number of companies each year — by design. Every engagement is led directly by Dr. Roxie Mooney and senior team members with direct healthcare exit experience. There is no junior handoff, no account management layer, and no project team you haven't met.
Enterprise healthcare Regulated environments Board-level communications PE-backed execution
YOUR NEXT STEP
Schedule your Strategic Fit Call
It’s a practical conversation to determine whether the Enterprise Value Creation System™ fits your situation and what will most effectively strengthen your valuation.
No pitch. No pressure. Just clarity.